SCHEMBL4068426

SCHEMBL4068426

N[C@@H](Cc1ccc(CNCCNc2ccccn2)cc1)C(=O)OC(=O)c1c(Cl)cccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ ITGB1 P05556 13/20 0.49
▸ ITGA5 P08648 10/20 0.49
▸ ITGB3 P05106 7/20 0.49
▸ ITGAV P06756 7/20 0.49
▸ KDM4E B2RXH2 1/20 0.40
▸ ITGB6 P18564 3/20 0.39
▸ ITGB5 P18084 2/20 0.39
▸ CXCR4 P61073 1/20 0.38
▸ NOS1 P29475 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ TPH1 P17752 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8234167 0.79 ITGB1 (0.65) ITGB1ITGA5ITGB3ITGAV
SCHEMBL4068703 0.79 ITGB1 (0.65) ITGB1ITGA5ITGB3ITGAV
SCHEMBL8234655 0.77 ITGB1 (0.78) ITGB1ITGA5ITGB3ITGAV
SCHEMBL4068425 0.77 ITGB1 (0.78) ITGB1ITGA5ITGB3ITGAV
SCHEMBL3019685 0.74 SLC7A5 (0.37) ITGB1ITGA5
SCHEMBL1324063 0.73 DPP4 (0.39) ITGB1ITGA5
SCHEMBL4064188 0.72 ITGB1 (0.53) ITGB1ITGA5ITGB3ITGAVITGB6
SCHEMBL297856 0.70 RAB9A (0.42) POLB
SCHEMBL8234588 0.70 ITGB1 (0.64) ITGB1ITGA5ITGB3ITGAVKDM4E
SCHEMBL4919562 0.69 ITGB3 (0.67) ITGB1ITGA5ITGB3ITGAVITGB6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049490-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS Astra Zeneca AB (SE) 2009-04-22 — — EP claimed
WO-2007141473-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS ASTRAZENECA AB (SE) 2007-12-13 — — WO claimed
Send feedback